4 Foot Lotions You’ll Swear by if You Have Diabetes
🧐 Did You Know? Diabetes can affect the skin’s ability to hold in moisture. Make sure to use a good lotion to keep your…
This study is for participants with Type 2 Diabetes currently taking Trulicity at a dose of 0.75 mg or 1.5 mg. Participants will either go on a higher dose of Trulicity or switch to Tirzepatide (Mounjaro). Mounjaro is a once-weekly injection for Type 2 Diabetes. The purpose of the study is to compare changes in A1C and weight loss.
Participants will receive the study med at no charge, and will be compensated for their time and travel.
To take part in the study, participants should be:
See if you qualify
CEO and Medical Director
Director of Clinical Services
Director of Clinical Research
Clinical Research Coordinator
Clinical Research Coordinator
Navigator/Study Start-up Manager
Clinical Research Coordinator
Clinical Research Coordinator